Nikita K. Mehra

38, Sardar Patel Road
Chennai, TN 600036, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.

Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.

Journal: British journal of haematology

Published: November 01, 2025

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels.

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels.

Journal: Blood advances

Published: March 13, 2025

Corrigendum to "Access to timely cancer treatment initiation in India: extent, determinants and trends" [The Lancet Regional Health - Southeast Asia, Volume 32, January 2025, 100514].

Corrigendum to "Access to timely cancer treatment initiation in India: extent, determinants and trends" [The Lancet Regional Health - Southeast Asia, Volume 32, January 2025, 100514].

Journal: The Lancet regional health. Southeast Asia

Published: March 03, 2025

Fludarabine - Total Body Irradiation-Based Myeloablative Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation: A 10-Year Single Centre Real-World Analysis.

Fludarabine - Total Body Irradiation-Based Myeloablative Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation: A 10-Year Single Centre Real-World Analysis.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: January 01, 2025

Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma.

Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma.

Journal: Current oncology reports

Published: November 12, 2024

Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.

Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.

Journal: Blood cancer journal

Published: September 24, 2024

Transplant in myeloma: individualized approaches needed depending on context, access and biology.

Transplant in myeloma: individualized approaches needed depending on context, access and biology.

Journal: Bone marrow transplantation

Published: August 16, 2024

Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.

Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.

Journal: The oncologist

Published: July 23, 2024

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma-Experience from an Indian Center.

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma-Experience from an Indian Center.

Journal: South Asian journal of cancer

Published: June 26, 2024

Access to timely cancer treatment initiation in India: extent, determinants and trends.

Access to timely cancer treatment initiation in India: extent, determinants and trends.

Journal: The Lancet regional health. Southeast Asia

Published: June 14, 2024

ROLE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN RELAPSED/ REFRACTORY HODGKIN'S LYMPHOMA: RETROSPECTIVE DATA FROM A TERTIARY CARE CENTRE IN INDIA.

ROLE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN RELAPSED/ REFRACTORY HODGKIN'S LYMPHOMA: RETROSPECTIVE DATA FROM A TERTIARY CARE CENTRE IN INDIA.

Journal: Blood cell therapy

Published: June 07, 2024

Research landscape of plasma cell disorders in South Asia: a call for collaboration.

Research landscape of plasma cell disorders in South Asia: a call for collaboration.

Journal: The Lancet. Haematology

Published: May 23, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026